Clinical Trials Insight: 700034255

Trial Profile

Clinical Trials Insight: 700034255

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 06 Jun 2008

At a glance

  • Drugs Ondansetron (Primary)
  • Indications Nausea; Vomiting
  • Focus Pharmacokinetics; Registrational
  • Sponsors Par Pharmaceutical Companies
  • Most Recent Events

    • 06 Jun 2008 New trial record.
    • 08 May 2008 Expect to file and NDA by end of year 2008.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top